AVOID CLINICAL TRIAL DISRUPTION IN SOUTH AFRICA

MARKEN UTILIZES GLOBAL NETWORK TO REACH PATIENTS THROUGHOUT THE WORLD

During this critical time, while countries like South Africa are extremely limited with transport options, Marken utilizes our global network to safely transport biological sample shipments out of the country and ship clinical drug products to sites and patients. Our fully operational status ensures we can move your clinical trial forward to/from challenging lanes or countries.

Contact your local Marken branch or your business development professional to learn more about our incentives to add new lanes to your trial and reach more patients.

 

STORE YOUR DRUGS CLOSER TO YOUR PATIENTS
MARKEN’S RELIABLE GMP DEPOTS ALLOW YOU TO STORE AND THEN TRANSPORT CLINICAL SHIPMENTS ON DEMAND

Our GMP/GDP-certified pharmaceutical supply centers are strategically placed worldwide to help your clinical drug program access patients in key recruitment areas, including Eastern Europe, South America, China and Europe.

Only Marken’s global network is designed to offer a fully compliant local solution to regionalize the distribution of crucial clinical products to sites, dramatically reducing the time it takes to reach patients after they become part of your clinical drug program.

Speak with a Marken expert to learn more about our global GMP Depot Network capabilities.

 

 About Marken

 Marken is a wholly owned subsidiary of the UPS Healthcare Division. With Polar Speed and Marken included, the UPS division staffs 128 locations with 5000 employees worldwide. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistics hubs in 54 locations worldwide for clinical trial material storage and distribution. Marken’s dedicated 1200 staff members manage 85,000 drug and biological shipment every month at all temperature ranges in more than 220 countries Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy as to Marken’ unique position in the pharma and logistics industry.

Issued April 2020

Back to Index